Aclarion, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
ACON$1.60-8.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Changes in Stockholders' Equity (Deficit)
| Series A · Series B · Series C | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Preferred Stock · Preferred Stock · Common Stock · Paid-In · Accumulated | ||||||||||||
| Shares · Value · Shares · Value · Shares · Value · Shares · Value · Capital · Deficit · Total | ||||||||||||
| For the Nine Months Ended September 30, 2024 | ||||||||||||
| Balance, December 31, 2023 | – | $– | – | $– | – | $– | 93 | $ | * | $43,553,531 | $(44,281,526) | $(727,995) |
| Share-based compensation | – | – | – | – | – | – | – | – | 85,827 | – | 85,827 | |
| Issuance of common stock and warrants related to public offering | – | – | – | – | – | – | 572 | * | 3,001,495 | – | 3,001,495 | |
| Issuance of common shares - equity line of credit | – | – | – | – | – | – | 50 | * | 1,449,532 | – | 1,449,532 | |
| Public offering and equity line issuance costs | – | – | – | – | – | – | – | – | (709,211) | – | (709,211) | |
| Issuance of common shares - debt for equity exchange | – | – | – | – | – | – | 71 | * | 1,771,606 | – | 1,771,606 | |
| Issuance of commitment shares - note financing | – | – | – | – | – | – | 1 | * | 33,297 | – | 33,297 | |
| Issuance of common shares related to restricted stock units | – | – | – | – | – | – | * | * | * | – | – | |
| Cashless exercise of pre-funded warrants | – | – | – | – | – | – | * | * | – | – | – | |
| Round up convention related to reverse stock split | – | – | – | – | – | – | 4 | * | – | – | – | |
| Net loss | – | – | – | – | – | – | – | – | – | (2,399,102) | (2,399,102) | |
| Balance, March 31, 2024 | – | $– | – | $– | – | $– | 791 | $ | * | $49,186,077 | $(46,680,628) | $2,505,449 |
| Share-based compensation | – | – | – | – | – | – | – | – | 70,305 | – | 70,305 | |
| Issuance of common shares related to restricted stock units | – | – | – | – | – | – | 1 | * | * | – | – | |
| Issuance of common shares - equity line of credit | – | – | – | – | – | – | 116 | * | 304,500 | – | 304,500 | |
| Net loss | – | – | – | – | – | – | – | – | – | (1,238,077) | (1,238,077) | |
| Balance, June 30, 2024 | – | $– | – | $– | – | $– | 908 | $ | * | $49,560,882 | $(47,918,705) | $1,642,177 |
| Share-based compensation | – | – | – | – | – | – | – | – | 74,706 | – | 74,706 | |
| Issuance of common shares related to restricted stock units | – | – | – | – | – | – | 1 | * | – | – | – | |
| Issuance of common shares related to RegA+ | – | – | – | – | – | – | 202 | 18 | 451,953 | – | 451,971 | |
| Issuance of B-Series preferred stock - debt for equity exchange | – | – | 930 | – | – | – | – | – | 930,052 | – | 930,052 | |
| B-Series preferred stock issuance costs | – | – | – | – | – | – | – | – | (35,000) | – | (35,000) | |
| C-Series preferred stock issuance costs | – | – | – | – | – | – | – | – | (55,000) | – | (55,000) | |
| Issuance of C-Series preferred stock | – | – | – | – | – | – | – | – | 602,900 | – | 602,900 | |
| Common stock issuance costs | – | – | – | – | 1,000 | – | – | – | (210,228) | – | (210,228) | |
| Issuance of C-Series warrants | – | – | – | – | – | – | – | – | 397,100 | – | 397,100 | |
| Issuance of RegA+ warrants | – | – | – | – | – | – | – | – | 77,283 | – | 77,283 | |
| Capitalization of B-Series preferred stock dividends | – | – | – | – | – | – | – | – | (12,142) | 12,142 | – | |
| Net income (loss) | – | – | – | – | – | – | – | – | – | (1,366,176) | (1,366,176) | |
| Balance, September 30, 2024 | – | $– | 930 | $– | 1,000 | $– | 1,111 | $18 | $51,782,506 | $(49,272,739) | $2,509,785 | |
*Rounds to less than one share or $1
Condensed Statements of Changes in Stockholders' Equity (Deficit)
(Continued)
| Series A · Series B · Series C | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Preferred Stock · Preferred Stock · Common Stock · Paid-In · Accumulated | ||||||||||||
| Shares · Value · Shares · Value · Shares · Value · Shares · Value · Capital · Deficit · Total | ||||||||||||
| For the Nine Months Ended September 30, 2025 | ||||||||||||
| Balance, December 31, 2024 | – | $– | 930 | $– | 874 | $– | 1,370 | $ | * | $52,232,368 | $(51,262,311) | $970,057 |
| Share-based compensation | – | – | – | – | – | – | – | – | 55,897 | – | 55,897 | |
| Registered Direct offerings of common stock | – | – | – | – | – | – | 19,144 | * | 5,167,927 | – | 5,167,927 | |
| Public offering of common stock and warrants | – | – | – | – | – | – | 16,048 | * | 14,554,544 | – | 14,554,544 | |
| Common stock issuance costs | – | – | – | – | – | – | – | – | (2,101,282) | – | (2,101,282) | |
| Redemption of Series B preferred stock | – | – | (930) | – | – | – | – | – | (1,213,590) | – | (1,213,590) | |
| Conversion of C-series preferred stock to common stock | – | – | – | – | (874) | – | 687 | * | – | – | – | |
| Exercise of C-series warrants | – | – | – | – | – | – | 629 | * | 336,441 | – | 336,441 | |
| Warrant amendment | – | – | – | – | – | – | – | – | 48,087 | – | 48,087 | |
| Alternative cashless exercise of B warrants | – | – | – | – | – | – | 544,299 | 5 | (5) | – | – | |
| Round-up conversion related to reverse stock splits | – | – | – | – | – | – | 161 | * | – | – | – | |
| Net loss | – | – | – | – | – | – | – | – | – | (2,037,436) | (2,037,436) | |
| Balance, March 31, 2025 | – | $– | – | $– | – | $– | 582,338 | $6 | $69,080,387 | $(53,299,747) | $15,780,645 | |
| Share-based compensation | – | – | – | – | – | – | – | – | 28,360 | – | 28,360 | |
| Round up conversion related to reverse stock splits | – | – | – | – | – | – | 33 | * | – | – | – | |
| Common stock issuance costs | – | – | – | – | – | – | – | – | (18,150) | – | (18,150) | |
| Net loss | – | – | – | – | – | – | – | – | – | (1,600,757) | (1,600,757) | |
| Balance, June 30, 2025 | – | $– | – | $– | – | $– | 582,371 | $6 | $69,090,597 | $(54,900,504) | $14,190,098 | |
| Share-based compensation | – | – | – | – | – | – | – | – | 16,746 | – | 16,746 | |
| Net loss | – | – | – | – | – | – | – | – | – | (1,706,294) | (1,706,294) | |
| Balance, September 30, 2025 | – | $– | – | $– | – | $– | 582,371 | $6 | $69,107,343 | $(56,606,798) | $12,500,551 | |
| * | Rounds to less than one share or $1 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.